Amylin proprotein processing generates progressively more amyloidogenic peptides that initially sample the helical state
Human amylin, or islet amyloid polypeptide, is a peptide cosecreted with insulin by the beta cells of the pancreatic islets of Langerhans. The 37-residue, C-terminally amidated human amylin peptide derives from a proprotein that undergoes disulfide bond formation in the endoplasmic reticulum and is...
Uloženo v:
| Vydáno v: | Biochemistry (Easton) Ročník 47; číslo 37; s. 9900 |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
16.09.2008
|
| Témata: | |
| ISSN: | 1520-4995, 1520-4995 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Human amylin, or islet amyloid polypeptide, is a peptide cosecreted with insulin by the beta cells of the pancreatic islets of Langerhans. The 37-residue, C-terminally amidated human amylin peptide derives from a proprotein that undergoes disulfide bond formation in the endoplasmic reticulum and is then subjected to four enzymatic processing events in the immature secretory granule. Human amylin forms both intracellular and extracellular amyloid deposits in the pancreas of most type II diabetic subjects, likely reflecting compromised secretory cell function. In addition, amylin processing intermediates, postulated to initiate intracellular amyloidogenesis, have been reported as components of intracellular amyloid in beta cells. We investigated the amyloidogenicity of amylin and its processing intermediates in vitro. Chaotrope-denatured amylin and amylin processing intermediates were subjected to size exclusion chromatography, affording high concentrations of monomeric peptides. NMR studies reveal that human amylin samples helical conformations. Under conditions mimicking the immature secretory granule (37 degrees C, pH 6), amylin forms amyloid aggregates more rapidly than its processing intermediates, and more rapidly than its reduced counterparts. Our studies also show that the amyloidogenicity of amylin and its processing intermediates is negatively correlated with net charge and charge at the C-terminus. Although our conditions may not precisely reflect those of amyloidogenesis in vivo, the lower amyloidogenicity of the processing intermediates relative to amylin suggests their presence in intracellular amyloid deposits in the increasingly stressed beta cells of diabetic subjects may be a consequence of general defects in protein homeostasis control known to occur in diabetes rather than serving as amyloid initiators. |
|---|---|
| AbstractList | Human amylin, or islet amyloid polypeptide, is a peptide cosecreted with insulin by the beta cells of the pancreatic islets of Langerhans. The 37-residue, C-terminally amidated human amylin peptide derives from a proprotein that undergoes disulfide bond formation in the endoplasmic reticulum and is then subjected to four enzymatic processing events in the immature secretory granule. Human amylin forms both intracellular and extracellular amyloid deposits in the pancreas of most type II diabetic subjects, likely reflecting compromised secretory cell function. In addition, amylin processing intermediates, postulated to initiate intracellular amyloidogenesis, have been reported as components of intracellular amyloid in beta cells. We investigated the amyloidogenicity of amylin and its processing intermediates in vitro. Chaotrope-denatured amylin and amylin processing intermediates were subjected to size exclusion chromatography, affording high concentrations of monomeric peptides. NMR studies reveal that human amylin samples helical conformations. Under conditions mimicking the immature secretory granule (37 degrees C, pH 6), amylin forms amyloid aggregates more rapidly than its processing intermediates, and more rapidly than its reduced counterparts. Our studies also show that the amyloidogenicity of amylin and its processing intermediates is negatively correlated with net charge and charge at the C-terminus. Although our conditions may not precisely reflect those of amyloidogenesis in vivo, the lower amyloidogenicity of the processing intermediates relative to amylin suggests their presence in intracellular amyloid deposits in the increasingly stressed beta cells of diabetic subjects may be a consequence of general defects in protein homeostasis control known to occur in diabetes rather than serving as amyloid initiators. Human amylin, or islet amyloid polypeptide, is a peptide cosecreted with insulin by the beta cells of the pancreatic islets of Langerhans. The 37-residue, C-terminally amidated human amylin peptide derives from a proprotein that undergoes disulfide bond formation in the endoplasmic reticulum and is then subjected to four enzymatic processing events in the immature secretory granule. Human amylin forms both intracellular and extracellular amyloid deposits in the pancreas of most type II diabetic subjects, likely reflecting compromised secretory cell function. In addition, amylin processing intermediates, postulated to initiate intracellular amyloidogenesis, have been reported as components of intracellular amyloid in beta cells. We investigated the amyloidogenicity of amylin and its processing intermediates in vitro. Chaotrope-denatured amylin and amylin processing intermediates were subjected to size exclusion chromatography, affording high concentrations of monomeric peptides. NMR studies reveal that human amylin samples helical conformations. Under conditions mimicking the immature secretory granule (37 degrees C, pH 6), amylin forms amyloid aggregates more rapidly than its processing intermediates, and more rapidly than its reduced counterparts. Our studies also show that the amyloidogenicity of amylin and its processing intermediates is negatively correlated with net charge and charge at the C-terminus. Although our conditions may not precisely reflect those of amyloidogenesis in vivo, the lower amyloidogenicity of the processing intermediates relative to amylin suggests their presence in intracellular amyloid deposits in the increasingly stressed beta cells of diabetic subjects may be a consequence of general defects in protein homeostasis control known to occur in diabetes rather than serving as amyloid initiators.Human amylin, or islet amyloid polypeptide, is a peptide cosecreted with insulin by the beta cells of the pancreatic islets of Langerhans. The 37-residue, C-terminally amidated human amylin peptide derives from a proprotein that undergoes disulfide bond formation in the endoplasmic reticulum and is then subjected to four enzymatic processing events in the immature secretory granule. Human amylin forms both intracellular and extracellular amyloid deposits in the pancreas of most type II diabetic subjects, likely reflecting compromised secretory cell function. In addition, amylin processing intermediates, postulated to initiate intracellular amyloidogenesis, have been reported as components of intracellular amyloid in beta cells. We investigated the amyloidogenicity of amylin and its processing intermediates in vitro. Chaotrope-denatured amylin and amylin processing intermediates were subjected to size exclusion chromatography, affording high concentrations of monomeric peptides. NMR studies reveal that human amylin samples helical conformations. Under conditions mimicking the immature secretory granule (37 degrees C, pH 6), amylin forms amyloid aggregates more rapidly than its processing intermediates, and more rapidly than its reduced counterparts. Our studies also show that the amyloidogenicity of amylin and its processing intermediates is negatively correlated with net charge and charge at the C-terminus. Although our conditions may not precisely reflect those of amyloidogenesis in vivo, the lower amyloidogenicity of the processing intermediates relative to amylin suggests their presence in intracellular amyloid deposits in the increasingly stressed beta cells of diabetic subjects may be a consequence of general defects in protein homeostasis control known to occur in diabetes rather than serving as amyloid initiators. |
| Author | Dyson, H Jane Balch, William E Kelly, Jeffery W Kroon, Gerard J A Yonemoto, Isaac T |
| Author_xml | – sequence: 1 givenname: Isaac T surname: Yonemoto fullname: Yonemoto, Isaac T organization: Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA – sequence: 2 givenname: Gerard J A surname: Kroon fullname: Kroon, Gerard J A – sequence: 3 givenname: H Jane surname: Dyson fullname: Dyson, H Jane – sequence: 4 givenname: William E surname: Balch fullname: Balch, William E – sequence: 5 givenname: Jeffery W surname: Kelly fullname: Kelly, Jeffery W |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18710262$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkE1LAzEQhoNUbK0e_AOSk7fVbDabTY6l-AUFL3peZrOzbST74SYr9t-b0grCwMy8PO8LM5dk1vUdEnKTsvuU8fShsooxxdV0RhZpzlkitM5n_-Y5ufT-kzEmWCEuyDxVRTRKviA_q3bvbEeHsY8V8Dga9N52W7rFDkcI6A_idjyo3-j2tO1HpBCdva37CFlDBxyCrSMZdhCo7Wyw4CLqoR0cRhXpDp014KgPMfKKnDfgPF6f-pJ8PD2-r1-Szdvz63q1SUCINCQqN0UtKsBMFJJpqQ4r5zVTRWN4XjVGSgXa8AywkarItESDCiTXALLK-ZLcHXPjBV8T-lC21ht0DjrsJ19KnXORiiyCtydwqlqsy2G0LYz78u9X_BfB_HAn |
| CitedBy_id | crossref_primary_10_1016_j_bbamem_2018_02_020 crossref_primary_10_1016_j_bpj_2009_08_041 crossref_primary_10_1093_infdis_jiz560 crossref_primary_10_1155_2015_849017 crossref_primary_10_1016_j_bbamem_2011_01_010 crossref_primary_10_1016_j_bbamem_2018_03_027 crossref_primary_10_1021_ja9010095 crossref_primary_10_1139_cjpp_2015_0117 crossref_primary_10_1016_j_bbrc_2011_06_133 crossref_primary_10_1016_j_bpj_2020_12_019 crossref_primary_10_1016_j_jmb_2009_04_077 crossref_primary_10_1016_j_bbapap_2022_140866 crossref_primary_10_1016_j_ijbiomac_2024_137930 crossref_primary_10_1016_j_abb_2019_01_032 crossref_primary_10_1021_ja910763m crossref_primary_10_1371_journal_pcbi_1003211 crossref_primary_10_1002_pro_211 crossref_primary_10_1016_j_bpj_2016_05_050 crossref_primary_10_1021_ja403147m crossref_primary_10_1093_protein_gzp029 crossref_primary_10_1208_s12249_013_9987_4 crossref_primary_10_1039_C2CC33432A crossref_primary_10_1016_j_bpj_2015_07_023 crossref_primary_10_1021_ja504031d crossref_primary_10_1016_j_bpj_2009_08_034 crossref_primary_10_1038_srep09228 crossref_primary_10_1155_2016_5639875 crossref_primary_10_1016_j_jmb_2021_167254 crossref_primary_10_1021_ja900285z crossref_primary_10_1038_s41598_017_08504_x crossref_primary_10_1021_ja204035k crossref_primary_10_1002_pro_145 crossref_primary_10_1155_2013_826706 crossref_primary_10_1016_j_bbagen_2016_01_008 crossref_primary_10_1002_prot_26432 crossref_primary_10_3390_metabo11080515 crossref_primary_10_3390_nu13124285 crossref_primary_10_1016_j_bbrc_2012_05_133 crossref_primary_10_1073_pnas_1309613110 crossref_primary_10_3390_ijms140612411 crossref_primary_10_1007_s10989_012_9325_9 crossref_primary_10_1002_prot_24338 crossref_primary_10_1371_journal_pone_0186219 crossref_primary_10_1016_j_bbamem_2018_03_006 crossref_primary_10_3390_ijms20061322 crossref_primary_10_1016_j_bbamem_2018_04_011 crossref_primary_10_1021_ja903814q crossref_primary_10_3389_fnmol_2020_00035 crossref_primary_10_1002_pro_4711 crossref_primary_10_1371_journal_pone_0134091 crossref_primary_10_1002_cbic_200900237 crossref_primary_10_1002_chem_202002114 crossref_primary_10_1016_j_bbamem_2011_06_012 crossref_primary_10_1016_j_chemphyslip_2009_03_008 crossref_primary_10_1124_jpet_123_001679 crossref_primary_10_1016_j_ejmech_2015_01_047 crossref_primary_10_1126_science_1173155 crossref_primary_10_1021_ol101981b crossref_primary_10_1016_j_bpc_2016_09_008 crossref_primary_10_1016_j_colsurfb_2012_01_021 crossref_primary_10_1002_chem_202103161 crossref_primary_10_1002_cbdv_202000842 crossref_primary_10_1038_s41594_020_0442_4 crossref_primary_10_1080_07391102_2013_832635 crossref_primary_10_1002_prot_25677 crossref_primary_10_1016_j_trsl_2019_08_001 crossref_primary_10_1002_smll_201805166 crossref_primary_10_3390_ijms21186530 crossref_primary_10_1007_s12010_012_9549_3 crossref_primary_10_1080_07391102_2023_2254411 crossref_primary_10_1002_cbic_201100025 crossref_primary_10_1016_j_jmb_2011_05_015 crossref_primary_10_1016_j_bpj_2013_08_026 crossref_primary_10_3390_ijms17111896 crossref_primary_10_1155_2016_1749196 crossref_primary_10_1002_1873_3468_12261 crossref_primary_10_1155_2016_2046327 crossref_primary_10_3389_fonc_2020_600824 crossref_primary_10_1016_j_jmb_2010_12_028 crossref_primary_10_1021_acschemneuro_5c00269 crossref_primary_10_1021_jacs_4c05297 crossref_primary_10_1039_C6CP01196A crossref_primary_10_1039_C6CP05590G crossref_primary_10_1016_j_bbamem_2018_02_005 crossref_primary_10_1016_j_jmb_2009_07_077 crossref_primary_10_1016_j_pep_2014_04_002 crossref_primary_10_1021_ja1069882 crossref_primary_10_1093_protein_gzp036 crossref_primary_10_3390_ijms14036241 crossref_primary_10_1016_j_bpj_2010_07_014 crossref_primary_10_1111_febs_15253 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1021/bi800828u |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Anatomy & Physiology Chemistry |
| EISSN | 1520-4995 |
| ExternalDocumentID | 18710262 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIA NIH HHS grantid: AG18917 – fundername: NIDDK NIH HHS grantid: R01 DK046335 – fundername: NIA NIH HHS grantid: R01 AG018917 – fundername: NIDDK NIH HHS grantid: DK46335 – fundername: NIDDK NIH HHS grantid: R37 DK046335 |
| GroupedDBID | --- -DZ -~X .55 .K2 23N 3O- 4.4 53G 55A 5GY 5RE 5VS 6TJ 7~N 85S AABXI ABBLG ABJNI ABLBI ABMVS ABOCM ABQRX ABUCX ACGFS ACJ ACNCT ACRPL ACS ADHLV ADNMO AEESW AENEX AETEA AFEFF AFFNX AGXLV AHGAQ ALMA_UNASSIGNED_HOLDINGS ANPPW ANTXH AQSVZ BAANH CGR CS3 CUPRZ CUY CVF D0L DU5 EBS ECM ED~ EIF EJD F5P GGK GNL IH9 IHE JG~ L7B LG6 NPM P2P ROL TN5 UI2 VF5 VG9 W1F WH7 X7M XSW YZZ ZCA ~02 ~KM 7X8 |
| ID | FETCH-LOGICAL-a441t-85c7d4bae34760968c7d422d087fc25bfc668a9c23aef687396ece8a629aa6b52 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 126 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000259119000019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1520-4995 |
| IngestDate | Thu Oct 02 10:33:43 EDT 2025 Mon Jul 21 05:46:38 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 37 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a441t-85c7d4bae34760968c7d422d087fc25bfc668a9c23aef687396ece8a629aa6b52 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | http://doi.org/10.1021/bi800828u |
| PMID | 18710262 |
| PQID | 69524143 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_69524143 pubmed_primary_18710262 |
| PublicationCentury | 2000 |
| PublicationDate | 2008-09-16 |
| PublicationDateYYYYMMDD | 2008-09-16 |
| PublicationDate_xml | – month: 09 year: 2008 text: 2008-09-16 day: 16 |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Biochemistry (Easton) |
| PublicationTitleAlternate | Biochemistry |
| PublicationYear | 2008 |
| SSID | ssj0004074 |
| Score | 2.3174567 |
| Snippet | Human amylin, or islet amyloid polypeptide, is a peptide cosecreted with insulin by the beta cells of the pancreatic islets of Langerhans. The 37-residue,... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 9900 |
| SubjectTerms | Amino Acid Sequence Amyloid - chemical synthesis Amyloid - chemistry Amyloid - metabolism Chromatography, Gel Circular Dichroism Humans Islet Amyloid Polypeptide Kinetics Molecular Sequence Data Nuclear Magnetic Resonance, Biomolecular |
| Title | Amylin proprotein processing generates progressively more amyloidogenic peptides that initially sample the helical state |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/18710262 https://www.proquest.com/docview/69524143 |
| Volume | 47 |
| WOSCitedRecordID | wos000259119000019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NS8MwFH9MJ-jFj82P-ZmDeCtr0zZNQZAxHF4cOyjsNtI00cLWTtcN99_7kq7gRTx4KW1I2pK-5v1e8svvAdy6ng4TT2BskujIQY-nndhVaMsYTHhUBanS3CabiIZDPh7Howbc13thDK2yHhPtQJ0W0syRd1kcorMJ_If5h2NyRpm11U0CjS1o-ghkjE1H4x9a4a7VYEYH5TqI68NaV4h63STjVrtt-TuutP5lcPC_NzuE_Q2uJL3KEI6gofIWtHs5xtSzNbkjlulpp9BbsNuvs7y14as3WyPSJPhMK9lQnZq9A-jTyJsVpUY0SiyPy5Su1HRNDDuXCGxZZGmBlTJJ5oYek2LN8l2UJDOcJDHFqgth9IexVJF3ZWYIp8RuYjqG18HjS__J2WRjcARCptLhoYzSIBHKDyKGgQ83l5SmLo-0pGGiJWNcxJL6QmnGIz9mSiouGI2FYElIT2A7L3J1BoR7aCESm2GwF8Q6ialwPWmkBfGeGLF24Kbu6Ql2h1nCELkqlotJ3dcdOK0-1mReiXJMPG6wEqPnf7a9gL2a9OGxS2hq_M_VFezIVZktPq-tEeFxOHr-Bphp1cc |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Amylin+proprotein+processing+generates+progressively+more+amyloidogenic+peptides+that+initially+sample+the+helical+state&rft.jtitle=Biochemistry+%28Easton%29&rft.au=Yonemoto%2C+Isaac+T&rft.au=Kroon%2C+Gerard+J+A&rft.au=Dyson%2C+H+Jane&rft.au=Balch%2C+William+E&rft.date=2008-09-16&rft.eissn=1520-4995&rft.volume=47&rft.issue=37&rft.spage=9900&rft_id=info:doi/10.1021%2Fbi800828u&rft_id=info%3Apmid%2F18710262&rft_id=info%3Apmid%2F18710262&rft.externalDocID=18710262 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1520-4995&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1520-4995&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1520-4995&client=summon |